MGMT gene promoter methylation in pediatric glioblastomas. - Wikidata - wikimedia - TriplyDB

MGMT gene promoter methylation in pediatric glioblastomas.

MGMT gene promoter methylation in pediatric glioblastomas.

http://www.wikidata.org/entity/Q43002702

about

Therapeutic approach beyond conventional temozolomide for newly diagnosed glioblastoma: Review of the present evidence and future direction Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment Genome-wide methylation profiling identifies an essential role of reactive oxygen species in pediatric glioblastoma multiforme and validates a methylome specific for H3 histone family 3A with absence of G-CIMP/isocitrate dehydrogenase 1 mutation.Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.Management of high-grade gliomas in the pediatric patient: Past, present, and future.Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge.Pediatric neuro-oncology: current status and future directions.Using the molecular classification of glioblastoma to inform personalized treatment.Extent of surgical resection and adjuvant temozolomide improves survival in pediatric GBM: a single center experience.Pediatric glioblastoma: a single institution experience.Pediatric gliosarcoma treated with adjuvant radiotherapy and temozolomide.Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers.Pediatric glioblastoma with oligodendroglioma component: aggressive clinical phenotype with distinct molecular characteristics.A huge intraventricular congenital anaplastic astrocytoma: case report with histopathological and genetic consideration.MGMT promoter gene methylation in pediatric glioblastoma: analysis using MS-MLPA.GSK3β‑mediated Ser156 phosphorylation modulates a BH3‑like domain in BCL2L12 during TMZ‑induced apoptosis and autophagy in glioma cells.

P2860

Q26774717-856E0405-EC03-40C5-84C8-AC5AED1EF1CE Q26785952-6F825F66-0EEF-4938-9734-AE5416BEBBC2 Q34511715-38FC8290-D1A7-424C-A1C4-177F2FA2C1C5 Q35070545-1B4AD502-FFD5-48E6-834C-456C4ABA8397 Q35206259-EBC150F0-E261-4993-A734-A1B3F8D1B859 Q35769714-CFD37217-D315-42DE-9D5B-6D60B3AD2BB7 Q37729676-AE02E3D9-918E-42C0-BE9E-2CCE47836CE9 Q38035070-DD4D4AEA-D9CC-4029-80ED-01A0CC272EED Q38151582-F7ACB7E8-24E1-43AB-91CE-BE322058171E Q38829504-BC8C89F2-338B-46A5-AB5A-5CA40430A833 Q40355125-32881E90-5E94-4E9C-9E2C-87FEC27D5060 Q40464642-C0675A96-6905-4258-A9D0-F2543F2F193F Q41264935-E37DF858-5272-42B9-A103-4BA78CD7BEC9 Q48109859-32A60AA1-481B-4615-B7B5-9D7E3AA49118 Q48801688-45FD4811-8C43-46FE-BFBC-22D54717824F Q49012285-7E5129BC-AFAD-4C82-BA3B-5AE2881EF315 Q54110692-36BE1011-E022-437F-A088-0B4F618B5576

P2860

MGMT gene promoter methylation in pediatric glioblastomas.

http://www.wikidata.org/entity/Q43002702

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

MGMT gene promoter methylation in pediatric glioblastomas.

@en

MGMT gene promoter methylation in pediatric glioblastomas.

@nl

type

label

MGMT gene promoter methylation in pediatric glioblastomas.

@en

MGMT gene promoter methylation in pediatric glioblastomas.

@nl

prefLabel

MGMT gene promoter methylation in pediatric glioblastomas.

@en

MGMT gene promoter methylation in pediatric glioblastomas.

@nl

P1433

Q43002702-7C6B208F-3171-4F56-AA10-729C1BBDD412

P1476

Q43002702-9B3E526E-329C-43F0-85E2-F0B0F7170468

P2093

Q43002702-1F71ED58-7F4C-40A7-8FE5-9B68C845AA24

Q43002702-4D4E40A9-7567-43D0-AE10-1C26563C805A

Q43002702-50419F11-C8FA-40C0-92CD-C04DD8E55A58

Q43002702-6B04D302-FF07-4E4F-BA5C-8AB44517753A

Q43002702-91E67EF5-8875-49F5-94A0-9119C8FB71A0

Q43002702-A11FE246-FBBC-4F93-8210-AF07756DDCD0

Q43002702-E050C1F0-510B-4144-B5AB-45CE88E00B35

Q43002702-F12907D4-9924-4D56-94A5-595DBD9FBCCD

P2860

Q43002702-0139505E-0198-4429-B35B-C78B893286E9

Q43002702-0A3C0163-7A84-40D7-AC61-8C2330920C1D

Q43002702-0D8BF6C7-B9EE-4C8E-A439-EBD6710CC22E

Q43002702-0DFE412D-A270-464F-9C8A-6B1ED922230B

Q43002702-105912A2-C827-48D5-A977-45F33C28B7EA

Q43002702-1D0AE3BD-663D-46DF-A88D-6C42A043C89E

Q43002702-1E6D9F0B-AF2C-4042-9376-13EEE6FC4DB9

Q43002702-265E9535-668A-4469-A869-604EB07D299C

Q43002702-2A069D4E-7E21-4FB0-87A5-70AC2B15D116

Q43002702-40D853E9-39A9-488D-9850-CCFB727CC329

P2888

Q43002702-02C25BBF-82F5-4CA6-8994-D2B0F1D0EE93

P304

Q43002702-4DF5A5F2-9853-49E8-A845-E66AAAF6DA0D

P31

Q43002702-3AAADF12-3229-4978-B576-BF49C560067B

P356

Q43002702-67608400-78FD-463E-9116-EFFCD0112C86

P433

Q43002702-9305042C-BF5F-454B-9246-C33723DF556A

P478

Q43002702-19305A7B-DD9C-43AE-94BA-5F9E457BECBE

P50

Q43002702-1596A9BA-7581-467A-903E-284E61BFD98D

Q43002702-E67DD8D7-7EDC-42B5-B8E6-1FA35B97D52D

P577

Q43002702-DF36F981-85AE-4677-A6B7-D9E4964DC56F

P5875

Q43002702-62D2DB5C-C6BB-4F41-ADD2-817D7A86D5AF

P6179

Q43002702-270502D5-1961-4264-8A90-396770EC9E57

P698

Q43002702-6C1DBF55-3B05-47FC-B13F-E0B6D664DD20

P356

S00381-010-1214-Y

P1433

Child's Nervous System

P1476

MGMT gene promoter methylation in pediatric glioblastomas

@en

P2093

Aditya Gupta

http://www.w3.org/2001/XMLSchema#string

Ayushi Jain

http://www.w3.org/2001/XMLSchema#string

Chitra Sarkar

http://www.w3.org/2001/XMLSchema#string

Deepak Kumar Gupta

http://www.w3.org/2001/XMLSchema#string

Mehar Chand Sharma

http://www.w3.org/2001/XMLSchema#string

Prerana Jha

http://www.w3.org/2001/XMLSchema#string

Tarun Puri

http://www.w3.org/2001/XMLSchema#string

Vaishali Suri

http://www.w3.org/2001/XMLSchema#string

P2860

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse.

Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study.

Temozolomide in paediatric high-grade glioma: a key for combination therapy?

Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).

Temozolomide and radiation for aggressive pediatric central nervous system malignancies.

Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.

A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood.

P2888

s00381-010-1214-y

P304

1613-1618

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00381-010-1214-Y

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Supriya Mallick

Arti Srivastava

P577

2010-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44807469

http://www.w3.org/2001/XMLSchema#string

P6179

1045792492

http://www.w3.org/2001/XMLSchema#string

P698

20585787

http://www.w3.org/2001/XMLSchema#string